163 related articles for article (PubMed ID: 22240262)
1. Post-translational oxidative modification of β2-glycoprotein I and its role in the pathophysiology of the antiphospholipid syndrome.
Mirarabshahi P; Abdelatti M; Krilis S
Autoimmun Rev; 2012 Sep; 11(11):779-80. PubMed ID: 22240262
[TBL] [Abstract][Full Text] [Related]
2. Autoantibodies to beta2-glycoprotein I in systemic lupus erythematosus and primary antiphospholipid antibody syndrome: clinical correlations in comparison with other antiphospholipid antibody tests.
Day HM; Thiagarajan P; Ahn C; Reveille JD; Tinker KF; Arnett FC
J Rheumatol; 1998 Apr; 25(4):667-74. PubMed ID: 9558167
[TBL] [Abstract][Full Text] [Related]
3. The avidity of anti-beta2-glycoprotein I antibodies in patients with or without antiphospholipid syndrome: a collaborative study in the frame of the European forum on antiphospholipid antibodies.
Cucnik S; Kveder T; Ulcova-Gallova Z; Swadzba J; Musial J; Valesini G; Avcin T; Rozman B; Bozic B
Lupus; 2011 Oct; 20(11):1166-71. PubMed ID: 21712304
[TBL] [Abstract][Full Text] [Related]
4. Antibodies against domain I of β2-glycoprotein I: the one and only?
Pelkmans L; de Laat B
Lupus; 2012 Jun; 21(7):769-72. PubMed ID: 22635228
[TBL] [Abstract][Full Text] [Related]
5. Autoantibody explosion in antiphospholipid syndrome.
Shoenfeld Y; Twig G; Katz U; Sherer Y
J Autoimmun; 2008; 30(1-2):74-83. PubMed ID: 18171610
[TBL] [Abstract][Full Text] [Related]
6. Circulating β2 glycoprotein I-IgG anti-β2 glycoprotein I immunocomplexes in patients with definite antiphospholipid syndrome.
Banzato A; Frasson R; Acquasaliente L; Bison E; Bracco A; Denas G; Cuffaro S; Hoxha A; Ruffatti A; Iliceto S; De Filippis V; Pengo V
Lupus; 2012 Jun; 21(7):784-6. PubMed ID: 22635233
[TBL] [Abstract][Full Text] [Related]
7. Oxidative post-translational modification of βeta 2-glycoprotein I in the pathophysiology of the anti-phospholipid syndrome.
Weaver JC; Krilis SA; Giannakopoulos B
Free Radic Biol Med; 2018 Sep; 125():98-103. PubMed ID: 29604397
[TBL] [Abstract][Full Text] [Related]
8. Antiphospholipid antibodies, antiphospholipid syndrome and infections.
Sène D; Piette JC; Cacoub P
Autoimmun Rev; 2008 Feb; 7(4):272-7. PubMed ID: 18295729
[TBL] [Abstract][Full Text] [Related]
9. Novel assays of thrombogenic pathogenicity in the antiphospholipid syndrome based on the detection of molecular oxidative modification of the major autoantigen β2-glycoprotein I.
Ioannou Y; Zhang JY; Qi M; Gao L; Qi JC; Yu DM; Lau H; Sturgess AD; Vlachoyiannopoulos PG; Moutsopoulos HM; Rahman A; Pericleous C; Atsumi T; Koike T; Heritier S; Giannakopoulos B; Krilis SA
Arthritis Rheum; 2011 Sep; 63(9):2774-82. PubMed ID: 21618459
[TBL] [Abstract][Full Text] [Related]
10. Anti-beta2-glycoprotein I autoantibodies, in vitro thrombin generation, and the antiphospholipid syndrome.
Hanly JG; Smith SA
J Rheumatol; 2000 Sep; 27(9):2152-9. PubMed ID: 10990227
[TBL] [Abstract][Full Text] [Related]
11. The value of IgA antiphospholipid testing for diagnosis of antiphospholipid (Hughes) syndrome in systemic lupus erythematosus.
Bertolaccini ML; Atsumi T; Escudero Contreras A; Khamashta MA; Hughes GR
J Rheumatol; 2001 Dec; 28(12):2637-43. PubMed ID: 11764209
[TBL] [Abstract][Full Text] [Related]
12. Val/Leu247 polymorphism of beta2-glycoprotein I in Brazilian patients with antiphospholipid syndrome--a genetic risk factor?
Pernambuco-Climaco JM; Brochado MJ; Freitas MV; Roselino AM; Louzada-Junior P
Ann N Y Acad Sci; 2009 Sep; 1173():509-14. PubMed ID: 19758193
[TBL] [Abstract][Full Text] [Related]
13. Prevalence of antibodies to beta2-glycoprotein I in systemic lupus erythematosus and their association with antiphospholipid antibody syndrome criteria: a single center study and literature review.
Bruce IN; Clark-Soloninka CA; Spitzer KA; Gladman DD; Urowitz MB; Laskin CA
J Rheumatol; 2000 Dec; 27(12):2833-7. PubMed ID: 11128672
[TBL] [Abstract][Full Text] [Related]
14. Avidity of anti-β2-glycoprotein I antibodies in patients with antiphospholipid syndrome.
Čučnik S; Kveder T; Artenjak A; Ulcova Gallova Z; Swadzba J; Musial J; Iwaniec T; Stojanovich L; Alessandri C; Valesini G; Avčin T; Cohen Tervaert JW; Rozman B; Božič B
Lupus; 2012 Jun; 21(7):764-5. PubMed ID: 22635226
[TBL] [Abstract][Full Text] [Related]
15. Mechanisms of disease: antiphospholipid antibodies-from clinical association to pathologic mechanism.
de Laat B; Mertens K; de Groot PG
Nat Clin Pract Rheumatol; 2008 Apr; 4(4):192-9. PubMed ID: 18285765
[TBL] [Abstract][Full Text] [Related]
16. Oxidized low-density lipoprotein/beta2-glycoprotein I complexes and autoantibodies to oxLig-1/beta2-glycoprotein I in patients with systemic lupus erythematosus and antiphospholipid syndrome.
Lopez D; Garcia-Valladares I; Palafox-Sanchez CA; De La Torre IG; Kobayashi K; Matsuura E; Lopez LR
Am J Clin Pathol; 2004 Mar; 121(3):426-36. PubMed ID: 15023048
[TBL] [Abstract][Full Text] [Related]
17. Clinical relevance of nitrated beta 2-glycoprotein I in antiphospholipid syndrome: Implications for thrombosis risk.
Krilis M; Qi M; Ioannou Y; Zhang JY; Ahmadi Z; Wong JWH; Vlachoyiannopoulos PG; Moutsopoulos HM; Koike T; Sturgess AD; Chong BH; Krilis SA; Giannakopoulos B
J Autoimmun; 2021 Aug; 122():102675. PubMed ID: 34098405
[TBL] [Abstract][Full Text] [Related]
18. Pathophysiology of beta2-glycoprotein I in antiphospholipid syndrome.
Matsuura E; Shen L; Matsunami Y; Quan N; Makarova M; Geske FJ; Boisen M; Yasuda S; Kobayashi K; Lopez LR
Lupus; 2010 Apr; 19(4):379-84. PubMed ID: 20353973
[TBL] [Abstract][Full Text] [Related]
19. Autoantibodies to domain 1 of beta 2 glycoprotein 1: a promising candidate biomarker for risk management in antiphospholipid syndrome.
Mahler M; Norman GL; Meroni PL; Khamashta M
Autoimmun Rev; 2012 Dec; 12(2):313-7. PubMed ID: 22652408
[TBL] [Abstract][Full Text] [Related]
20. Obstetric and vascular APS: same autoantibodies but different diseases?
Meroni PL; Raschi E; Grossi C; Pregnolato F; Trespidi L; Acaia B; Borghi MO
Lupus; 2012 Jun; 21(7):708-10. PubMed ID: 22635208
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
